Journal of Surgical Research
Volume 152, Issue 1 , Pages 76-83 , March 2009

PKC and MLCK-Dependent, Cytokine-Induced Rat Coronary Endothelial Dysfunction

  • John H. Tinsley, Ph.D.

      Affiliations

    • Department of Internal Medicine, Scott and White Hospital, Temple, Texas
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Internal Medicine, Scott and White Memorial Hospital, 702 SW HK Dodgen Loop, Temple, TX 76504
    • ,
  • Felicia A. Hunter, B.S.

      Affiliations

    • Department of Surgery, Scott and White Hospital, Temple, Texas
    • ,
  • Ed W. Childs, M.D.

      Affiliations

    • Department of Surgery, Scott and White Hospital, Temple, Texas

Received 30 October 2007

References 

  1. Kapadia S, Lee JR, Torre-Amione G, et al. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96:1042
  2. Bozkurt B, Kribbs S, Clubb FJ. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998;97:1382
  3. Kubota T, McTiernan CF, Frye CS, et al. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-α. Circ Res. 1997;81:627
  4. Thaik CM, Calderone A, Takahashi N, et al. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 1995;96:1093
  5. Seta Y, Shan K, Bozkurt B, et al. Basic mechanisms in heart failure: The cytokine hypothesis. J Card Fail. 1996;2:243
  6. Anker SD, Clark AL, Kemp M, et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: Possible relation to muscle wasting. J Am Coll Cardiol. 1997;30:997
  7. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236
  8. Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704
  9. Funakoshi H, Kubota T, Machida Y, et al. Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-α. Am J Physiol Heart Circ Physiol. 2002;282:H2159
  10. Agnoletti L, Curello S, Bachetti T, et al. Serum from patients with severe heart failure down-regulates eNOS and is proapoptotic: Role of tumor necrosis factor-α. Circulation. 1999;100:1983
  11. Anker SD, Volterrani M, Egerer KR, et al. Tumor necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure. Q J Med. 1998;91:199
  12. Guillen I, Blanes M, Gomez-Lechon MJ, et al. Cytokine signaling during myocardial infarction: Sequential appearance of IL-1β and IL-6. Am J Physiol Reg Int Comp Physiol. 1995;269:R229–R235
  13. Dibbs Z, Thornby J, White BG, et al. Natural variability of circulating level of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials. J Am Coll Cardiol. 1999;33:1935
  14. Francis SE, Holden H, Holt CM, et al. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol. 1998;30:215
  15. Dejana E, Corada M, Lampugnani MG. Endothelial cell-to-cell junctions. FASEB J. 1995;9:910
  16. Rubin LL. Endothelial cells: Adhesion and tight junctions. Curr Opin Cell Biol. 1992;4:830
  17. Kemler R. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 1993;9:317
  18. Lampugnani MG, Corada M, Caveda L, et al. The molecular organization of endothelial cell to cell junctions: Differential association of plakoglobin, β-catenin, and α-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol. 1995;129:203
  19. Kypta RM, Su H, Reichardt LF. Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex. J Cell Biol. 1996;134:1519
  20. Matsuyoshi N, Hamaguchi M, Taniguchi S, et al. Cadherin-mediated cell–cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol. 1992;118:703
  21. Lampugnani MG, Corada M, Andriopoulou P, et al. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J Cell Sci. 1997;110:2065
  22. Tinsley JH, Teasdale NR, Yuan SY. Involvement of PKCδ and PKD in pulmonary microvascular endothelial cell hyperpermeability. Am J Physiol Cell Physiol. 2004;286:C105
  23. Tinsley JH, Wu MH, Ma W, et al. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem. 1999;274:24930
  24. Tinsley JH, Teasdale NR, Yuan SY. Myosin light chain phosphorylation and pulmonary endothelial cell hyperpermeability in burns. Am J Physiol Lung Cell Mol Physiol. 2004;286:L841
  25. Igawa A, Nozawa T, Yoshida N, et al. Heterogeneous cardiac sympathetic innervation in heart failure after myocardial infarction of rats. Am J Physiol Heart Circ Physiol. 2000;278:H1134
  26. Nonomura M, Nozawa T, Matsuki A, et al. Ischemia-induced norepinephrine release, but not norepinephrine-derived free radicals, contributes to myocardial ischemia-reperfusion injury. Circ J. 2005;69:590
  27. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503
  28. Sitniewska EM, Wisniewska RJ. Influence of secretin and L-NAME on vascular permeability in the coronary circulation of intact and diabetic rats. Reg Pep. 2001;96:105
  29. Tinsley JH, Breslin JW, Teasdale NR, et al. PKC-dependent, burn-induced adherens junction reorganization and barrier dysfunction in pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;289:L217
  30. Yuan SY, Ustinova EE, Wu MH, et al. Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circ Res. 2000;87:412
  31. Desai TR, Leeper NJ, Hynes KL, et al. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res. 2002;104:118
  32. Ferro T, Neumann P, Gertzberg N, et al. Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Physiol. 2000;278:L1107
  33. Maruyama K, Mori Y, Murasawa S, et al. Interleukin-1β up-regulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J Mol Cell Cardiol. 1999;31:607
  34. Mochly-Rosen D, Gordon AS. Anchoring proteins for protein kinase C: A means for isozyme selectivity. FASEB J. 1998;12:35
  35. Ron D, Kazanietz MG. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J. 1999;13:1658
  36. Idris I, Gray S, Donnelly R. Protein kine C-β inhibition and diabetic microangiopathy: Effects on endothelial permeability. Eur J Pharmacol. 2004;485:141
  37. Singh I, Knezevic N, Ahmmed GU, et al. Galphaq-TRPC6-mediated Ca2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin. J Biol Cell. 2007;282:7833
  38. Rubinfeld B, Robbins P, El-Gamil M, et al. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science. 1997;275:1752

PII: S0022-4804(08)00098-X

doi: 10.1016/j.jss.2008.02.022

Journal of Surgical Research
Volume 152, Issue 1 , Pages 76-83 , March 2009

Article Tools

* Image Usage & Resolution